These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31128566)

  • 21. Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex.
    Liuzzi GM; Mastroianni CM; Vullo V; Jirillo E; Delia S; Riccio P
    J Neuroimmunol; 1992 Feb; 36(2-3):251-4. PubMed ID: 1370671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury.
    Bohnert S; Wirth C; Schmitz W; Trella S; Monoranu CM; Ondruschka B; Bohnert M
    Int J Legal Med; 2021 Jul; 135(4):1525-1535. PubMed ID: 33895854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples.
    Takahashi H; Aoki Y; Nakajima A; Sonobe M; Terajima F; Saito M; Miyamoto T; Koyama K; Yamamoto K; Furuya T; Koda M; Ohtori S; Yamazaki M; Nakagawa K
    Eur Spine J; 2018 Aug; 27(8):1824-1830. PubMed ID: 29557051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
    Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
    J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.
    Bacioglu M; Maia LF; Preische O; Schelle J; Apel A; Kaeser SA; Schweighauser M; Eninger T; Lambert M; Pilotto A; Shimshek DR; Neumann U; Kahle PJ; Staufenbiel M; Neumann M; Maetzler W; Kuhle J; Jucker M
    Neuron; 2016 Jul; 91(1):56-66. PubMed ID: 27292537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and cerebrospinal fluid levels of visinin-like protein-1 in acute encephalopathy with biphasic seizures and late reduced diffusion.
    Hasegawa S; Matsushige T; Inoue H; Takahara M; Kajimoto M; Momonaka H; Oka M; Isumi H; Emi S; Hayashi M; Ichiyama T
    Brain Dev; 2014 Aug; 36(7):608-12. PubMed ID: 24075506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
    Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration.
    Brureau A; Blanchard-Bregeon V; Pech C; Hamon S; Chaillou P; Guillemot JC; Barneoud P; Bertrand P; Pradier L; Rooney T; Schussler N
    Neurobiol Dis; 2017 Aug; 104():73-84. PubMed ID: 28392472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
    Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
    Arch Neurol; 1999 Jun; 56(6):673-80. PubMed ID: 10369305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.
    Bäckström DC; Eriksson Domellöf M; Linder J; Olsson B; Öhrfelt A; Trupp M; Zetterberg H; Blennow K; Forsgren L
    JAMA Neurol; 2015 Oct; 72(10):1175-82. PubMed ID: 26258692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults.
    Idland AV; Sala-Llonch R; Borza T; Watne LO; Wyller TB; Brækhus A; Zetterberg H; Blennow K; Walhovd KB; Fjell AM
    Neurobiol Aging; 2017 Jan; 49():138-144. PubMed ID: 27794264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
    Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    Muszyński P; Kulczyńska-Przybik A; Borawska R; Litman-Zawadzka A; Słowik A; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Mroczko B
    J Alzheimers Dis; 2017; 59(3):903-912. PubMed ID: 28697565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Kirkwood CM; MacDonald ML; Schempf TA; Vatsavayi AV; Ikonomovic MD; Koppel JL; Ding Y; Sun M; Kofler JK; Lopez OL; Yates NA; Sweet RA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):175-82. PubMed ID: 26769253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.
    Verbeek MM; De Jong D; Kremer HP
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):25-40. PubMed ID: 12542908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.
    Brettschneider J; Petzold A; Schottle D; Claus A; Riepe M; Tumani H
    Dement Geriatr Cogn Disord; 2006; 21(5-6):291-5. PubMed ID: 16484807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
    Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.